Doctors are already able to calculate patients’ risk of getting cardiovascular disease based on their electronic medical records, including age, gender and smoking habits. Adding genetic assessments to the mix will make their job easier.
The Maltese EU presidency will seek more transparency in the way pharmaceutical companies negotiate with member states on medicines’ pricing, Health Minister Chris Fearne said in an interview with EurActiv.
EXCLUSIVE / National healthcare systems should embrace the digital era and use Health Technology Assessment (HTA) to become truly sustainable and cost-effective, European Commissioner for Health and Food Safety Vytenis Andriukaitis told EurActiv.com in an interview.
A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EurActiv.com
The internet provides a vast marketplace for new dangerous substances and drug prevention authorities risk being left in the wake of dealers and distributors, warned the head of the EMCDDA, Alexis Goosdeel. EurActiv Germany reports.
Ken Gabriel has dedicated his life to innovation and entrepreneurship at Google, and the Defence Advanced Research Projects Agency (DARPA). For Gabriel innovation boils down to “satisfying an unmet need”.
SPECIAL REPORT / Europe needs fewer specialised doctors and more drugs and treatments to target personal ailments with pinpoint accuracy, policymakers at the Gastein Health Forum heard yesterday (3 October).